CCR3 and breast carcinoma: MSC have been demonstrated to secrete among other chemokines, also CCL5, which interacts with specific cytokine receptors such as CCR1, CCR3, and CCR5. CCL5 paracrine signaling was found to promote the migratory, invasive, and metastatic properties of breast cancer cells [24].